Vascular smooth muscle growth: Autocrine growth mechanisms

Physiological Reviews

Volumn 81, Issue 3, 2001, Pages 999-1030

  Berk, Bradford C ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; REACTIVE OXYGEN METABOLITE; TYROSINE KINASE RECEPTOR;

AUTOCRINE EFFECT; CELL COUNT; CELL CULTURE; CELL CYCLE; CELL HYPERPLASIA; CELL PROLIFERATION; CELL TYPE; DNA CONTENT; EXTRACELLULAR MATRIX; GROWTH REGULATION; HUMAN; HUMAN CELL; MUSCLE GROWTH; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

EID: 0034953381     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.2001.81.3.999     Document Type: Review

References (349)

1. Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: A link between angiotensin II and intimal thickening
2. Differential regulation of acidic and basic fibroblast growth factor gene expression in fibroblast growth factor-treated rat aortic smooth muscle cells
3. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop
4. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspective
5. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor
6. Restenosis after coronary angioplasty
7. Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta
8. Localization and effects of hepatocyte growth factor on smooth muscle cells during neointimal formation after balloon denudation
9. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction
10. - in vascular smooth muscle cells
11. Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway
12. Adrenomedullin acts via stimulation of cyclic AMP and not via calcium signalling in vascular cells in culture
13. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
14. Constitutive expression of interleukin-1α precursor promotes human vascular smooth muscle cell proliferation
15. Human vascular smooth muscle cells produce an intracellular form of interleukin-1 receptor antagonist
16. Calcitonin gene-related peptide in the cardiovascular system: Characterization of receptor populations and their (patho)physiological significance
17. Evidence for cultured human vascular smooth muscle cell heterogeneity: Isolation of clonal cells and study of their growth characteristics
18. Neural crest cell contribution to the developing circulatory system: Implications for vascular morphology?
19. Angiotensin II signal transduction in vascular smooth muscle: Role of tyrosine kinases
20. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction
21. Autocrine and paracrine growth mechanisms in vascular smooth muscle
22. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size
23. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways
24. Thrombin-stimulated events in cultured vascular smooth-muscle cells
25. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells
26. Intraluminal pressure is essential for the maintenance of smooth muscle caldesmon and filamin content in aortic organ culture
27. Effect of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat
28. Growth stimulating effect of catecholamines on rat aortic smooth muscle cells in culture
29. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening
30. Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cells
31. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation
32. Chaperone function of Hsp90-associated proteins
33. Cell cycle progression: New therapeutic target for vascular proliferative disease
34. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages
35. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only
36. An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair
37. Autocrine induction of DNA synthesis by mechanical injury of cultured smooth muscle cells. Potential role of FGF and PDGF
38. Effect of perindopril on the development of atherosclerosis in the cholesterol-fed rabbit
39. Vascular thrombin receptor regulation in hypertensive rats
40. Mechanisms of angiogenesis and arteriogenesis
41. Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes
42. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2
43. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens
44. Geometric control of cell life and death
45. i, protein kinase C, and calcium
46. Induction of DNA synthesis by a single transient mechanical stimulus of human vascular smooth muscle cells. Role of fibroblast growth factor-2
47. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits
48. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
49. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium
50. Hypoxia stimulates proliferation and interleukin-1α production in human vascular smooth muscle cells
51. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
52. Protease-activated receptors and platelet function
53. Involvement of second messenger systems in stimulation of angiotenisn converting enzyme of bovine endothelial cells
54. Endothelial cells, hemodynamic forces, and the localization of atherosclerosis
55. How do vascular endothelial cells respond to flow?
56. Angiotensin II induction of osteopontin expression and DNA replication in rat arteries
57. G-protein coupled and tyrosine kinase receptors: Evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells
58. Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells
59. Angiotensin II regulates insulin like growth factor-1 gene expression in vascular smooth muscle cells
60. Luminal surface concentration of lipoprotein (LDL) and its effect on the wall uptake of cholesterol by canine carotid
61. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro
62. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart
63. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice
64. Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells
65. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide
66. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen
67. Endothelin in hypertensive resistance arteries. Intraluminal and extraluminal dysfunction
68. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells
69. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells
70. Vascular renin-angiotensin: A possible autocrine or paracrine system in control of vascular function
71. Circulating versus local renin-angiotensin system in cardiovascular homeostasis
72. Molecular mechanisms of vascular renin-angiotensin system in neointimal hyperplasia
73. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells
74. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells
75. Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells
76. Heterologous in vivo processing of human preproendothelin 1 into bioactive peptides
77. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta
78. Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells
79. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF
80. Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF
81. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells
82. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT (1) receptor, transforming growth factor-beta, and tyrosine phosphorylation
83. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells
84. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities
85. Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling
86. GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells
87. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats
88. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance
89. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion
90. The gene for the atrial natriuretic factor is expressed in the aortic arch
91. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
92. Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells
93. Time course of flow-induced smooth muscle cell proliferation and intimal thickening in endothelialized baboon vascular grafts
94. Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells
95. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
96. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques
97. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II
98. Smooth muscle cell origin and its relation to heterogeneity in development and disease
99. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries
100. Effect of active oxygen species on intimal proliferation in rat aorta after arterial injury
101. Clonal growth of bovine vascular endothelial cells: Fibroblast growth factor as a survival agent
102. Expression of IGF-1, IGF-1 receptor and TGF-beta following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: An immunocytochemical study
103. Oxidative stress and cardiovascular disease
104. Angiotensin II stimulates NADH and NADPH oxidase activation in cultured vascular smooth muscle cells
105. Angiotensin II signaling in vascular smooth muscle. New concepts
106. Redox control of vascular smooth muscle proliferation
107. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism
108. Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-β
109. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27
110. The third cytoplasmic loop of the angiotensin type I receptor exerts differential effects on ERK1/2 and apoptosis via Ras- and Rap1-dependent pathways
111. Activation of human peripheral monocytes by angiotensin II
112. Stimulation of autocrine platelet-derived growth factor AA-homodimer and transforming growth factor beta in vascular smooth muscle cells
113. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: A novel autocrine function
114. Free radicals, reactive oxygen species and human disease: A critical evaluation with special reference to atherosclerosis
115. Mechanical and morphological properties of arterial resistance vessels in young and old spontaneously hypertensive rats
116. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors
117. Cyclophilin: A specific cytosolic binding protein for cyclosporin A
118. Regenerating endothelial cells express insulin-like growth factor-I immunoreactivity after arterial injury
119. Isolation and amino acid sequence of cyclophilin
120. Pathogenesis of arterial vascular disease
121. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice
122. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat
123. Small artery structure in hypertension. Dual processes of remodeling and growth
124. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
125. 2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor
126. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
127. Endothelin is a potent mitogen for rat vascular smooth muscle cells
128. Progressive modulation of endothelial phenotype during in vitro blood vessel formation
129. Activation of PDGF receptor alpha in vascular smooth muscle cells by mechanical stress
130. Developmental biology of the vascular smooth muscle cell: Building a multilayered vessel wall
131. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells
132. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells
133. Integrins: Versatility, modulation, and signaling in cell adhesion
134. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice
135. Expression of heparin-binding epidermal growth factor-like growth factor in neointimal cells induced by balloon injury in rat carotid arteries
136. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner
137. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases
138. Demonstration of activin-A in arteriosclerotic lesions
139. Expression of follistatin, an activin-binding protein, in vascular smooth muscle cells and arteriosclerotic lesions
140. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II
141. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells
142. Transforming growth factor beta 1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells
143. A novel putative tyrosine kinase receptor with oncogenic potential
144. Differential distribution of 70-kD heat shock protein in atherosclerosis. Its potential role in arterial SMC survival
145. Exogenous HSP70 becomes cell associated, but not internalized, by stressed arterial smooth muscle cells
146. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells
147. Production of activin A and follistatin in cultured rat vascular smooth muscle cells
148. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor
149. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells
150. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells, and smooth muscle cells
151. Balloon angioplasty induces heat shock protein 70 in human blood vessels
152. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
153. Stress-induced proteins in aortic smooth muscle cells and aorta of hypertensive rats
154. Flow affects development of intimal hyperplasia after arterial injury in rats
155. Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts
156. Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II
157. Modulation of growth of vascular smooth muscle cells by activin A
158. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages
159. Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells
160. Molecular biology of the natriuretic peptides and their receptors
161. Vascular natriuretic peptide
162. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
163. Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat
164. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids
165. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors
166. Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesteryl ester enrichment and 25-hydroxycholesterol
167. Acute reductions in blood flow and shear stress induce platelet-derived growth factor-A expression in baboon prosthetic grafts
168. Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly
169. Angiotensin II stimulates a specific increase in Na/K ATPase in hypertrophied rat aortic smooth muscle cells
170. +-adenosine triphosphatase regulation in hypertrophied vascular smooth muscle cells
171. Pulsatile flow in a model carotid bifurcation
172. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress
173. Perinatal aortic growth in lambs: Relation to blood flow changes at birth
174. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent
175. Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats
176. Inhibition of nuclear polyploidy by propranolol in aortic smooth muscle cells of hypertensive rats
177. Elastin is an essential determinant of arterial morphogenesis
178. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-beta
179. Purification of a secreted protein factor induced by reactive oxygen species (ROS) in vascular smooth muscle cells (VSMC)
180. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells
181. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells
182. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque
183. A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor-B chain mRNA
184. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells
185. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes
186. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. She phosphorylation and receptor endocytosis correlate with activation of Erk kinases
187. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation
188. Control of smooth muscle cell growth by components of the extracellular matrix: Autocrine role for thrombospondin
189. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta
190. Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in aorta
191. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury
192. Production of transforming growth factor beta 1 during repair of arterial injury
193. Physiological fluid shear stress causes down-regulation of endothelin-1 mRNA in bovine aortic endothelium
194. Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries
195. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade
196. Cellular functions of immunophilins
197. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation
198. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
199. Norepinephrine release and ventricular fibrillation in myocardial ischemia/reperfusion: Roles of angiotensin and bradykinin
200. Endothelin in vascular biology
201. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
202. Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats
203. Integrins, adhesion and apoptosis
204. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth
205. Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells
206. Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro
207. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet
208. Novel cardiovascular actions of the activins
209. Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo
210. Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms
211. Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth
212. Effect of a nonhypotensive long-term infusion of ANP on the mechanical and structural properties of the arterial wall in Wistar-Kyoto and spontaneously hypertensive rats
213. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional dissector
214. Vascular remodeling
215. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrower lumen, a thicker media and a greater number of smooth muscle cell layers
216. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor
217. Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall
218. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer
219. Alpha1-adrenergic stimulation and beta2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells
220. Expression of local hepatocyte growth factor system in vascular tissues
221. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure
222. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: Potential role of HGF in cardiovascular disease
223. 2+-mobilizing growth factors
224. Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells
225. Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors
226. Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HBEGF in the formation of coronary atherosclerosis
227. Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy
228. Thrombin receptor expression in normal and atherosclerotic human arteries
229. Smooth muscle cell expression of extracellular matrix genes after arterial injury
230. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein
231. Structure and activation of the large latent transforming growth factor-beta complex
232. Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase
233. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: Evidence for a novel endothelial cell survival pathway
234. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells
235. Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells
236. Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor
237. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy and hyperplasia
238. Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy and hyperplasia in the spontaneously hypertensive rat
239. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells
240. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells
241. Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. Identification by comparative protein phenotyping and microsequencing
242. Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo
243. Heparin-binding epidermal growth factor-like growth factor regulates fibroblast growth factor-2 expression in aortic smooth muscle cells
244. Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells
245. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity
246. The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells
247. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II
248. C-type natriuretic peptide inhibits growth factor-independent synthesis in smooth muscle cells
249. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
250. Steroid receptor interactions with heat shock protein and immunophilin chaperones
251. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
252. Human cyclophilin B: A second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence
253. Noradrenaline induces the polyploidization of smooth muscle cells: The synergism of second messengers
254. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA
255. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases
256. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
257. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression
258. Hydrogen peroxide-induced c-fos expression is mediated by ara- chidonic acid release: Role of protein kinase C
259. + antiporter gene expression in vascular smooth muscle cells by hypertrophic and hyperplastic stimuli
260. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue
261. Factors controlling the development of arterial lesions after injury
262. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells
263. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo
264. Elastogenic cells in the developing cardiovascular system. Smooth muscle, nonmuscle, and cardiac neural crest
265. Mechanisms of atherosclerosis - A review
266. The pathogenesis of atherosclerosis: A perspective for the 1990s
267. Atherosclerosis - An inflammatory disease
268. Localization of PDGF-B protein in macrophages in all phases of atherogenesis
269. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling
270. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis
271. Proteoglycans as modulators of growth factor activities
272. Human coronary transplantation-associated arteriosclerosis - Evidence for a chronic immune reaction to activated graft endothelial cells
273. Fibronectin biosynthesis in the rat aorta in vitro: Changes due to experimental hypertension
274. Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart
275. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system
276. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells
277. Molecular mechanisms of coronary collateral vessel growth
278. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells
279. Vascular biology of endothelin
280. Genes specifically expressed at growth arrest of mammalian cells
281. Human cyclophilin C: Primary structure, tissue distribution, and determination of binding specificity for cyclosporins
282. Ligation of CD40 activates interleukin 1β-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1β
283. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits
284. Integrins: Emerging paradigms of signal transduction
285. Kinetics of atherosclerosis: A stem cell model
286. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries
287. Induction of endothelin secretion by angiotensin II: Effects on growth and synthetic activity of vascular smooth muscle cells
288. Hypoxia and hypoxia/reoxygenation activate Src family tyrosine kinases and p21ras in cultured rat cardiac myocytes
289. Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells
290. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes
291. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner
292. Nature and origin of the neointima in whole vessel wall organ culture of the human saphenous vein
293. Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: Implications in vascular hyperplasia
294. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells
295. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β
296. TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms
297. The role of secondary growth factor production in thrombin-induced proliferation of vascular smooth muscle cells
298. Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA
299. Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells
300. Angiotensin II prevents serum deprivation-induced apoptosis of vascular smooth muscle cells by inhibiting c-Jun N-terminal kinase
301. Phenotype-related alteration in expression of natriuretic peptide receptor in aortic smooth muscle cells
302. Endothelial cells actively synthesize and secrete adrenomedullin
303. Production and secretion of adrenomedullin from vascular smooth muscle cells: Augmented production by tumor necrosis factor-alpha
304. Cell transformation by the superoxide-generating oxidase Mox1
305. 2 for platelet-derived growth factor signal transduction
306. Effects of hypertension on fibronectin expression in the rat aorta
307. Modulation of extracellular matrix gene expression by heparin and endothelial cell growth factor in human smooth muscle cells
308. Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin
309. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells
310. Cell population kinetics in atherogenesis. Cell births and losses in intimal cell mass-derived lesions in the abdominal aorta of swine
311. Activation of p53 and its target genes p21 (WAF1/Cip1), and PAG608/Wig-1 in ischemic preconditioning
312. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease
313. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta
314. Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family
315. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes
316. Laminar shear stress: Mechanisms by which endothelial cells transduce an atheroprotective force
317. Role of NO in flow-induced remodeling of the rabbit common carotid artery
318. The Na/K/2Cl cotransporter is increased in hypertrophied vascular smooth muscle cells
319. Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-beta 1 and tissue-type plasminogen activator
320. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy
321. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells
322. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
323. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated
324. Alpha1-adrenergic blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery
325. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1
326. Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters
327. Local renin-angiotensin system in the micro-circulation of spontaneously hypertensive rats
328. Smooth muscle cells and fibroblasts of the coronary arteries derive from epithelial-mesenchymal transformation of the epicardium
329. Native and activated forms of alpha 2-macroglobulin increase expression of platelet-derived growth factor alpha-receptor in vascular smooth muscle cells. Evidence for autocrine transforming growth factor-beta activity
330. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin
331. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: Evidence for common signaling mechanisms
332. Expression of gax, a growth arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury
333. Contribution of adventitial myofibroblasts to vascular remodeling and lesion formation after experimental angioplasty in pig coronary arteries
334. Characterization of thrombin receptor expression during vascular lesion formation
335. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF
336. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions
337. Strain-responsive regions in the platelet-derived growth factor-A gene promoter
338. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor)
339. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model
340. The predominant form of fibroblast growth factor receptor expressed by proliferating human arterial smooth muscle cells in culture is type I
341. Angiotensin II type 2 receptor mediates programmed cell death
342. Role of endothelin-1/endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice
343. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
344. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
345. 2 in angiotensin II-induced vascular hypertrophy
346. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress
347. Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: Blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3′-kinase
348. Signal transduction in arteriosclerosis: Mechanical stress-activated MAP kinases in vascular smooth muscle cells (review)
349. Induction of platelet-derived growth factor chain A gene expression in human smooth muscle cells by oxidized low density lipoproteins